Skip to content
Home
About us
Our Team
Scientific Advisors
Our Product Pipeline
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Our Team
Scientific Advisors
Our Product Pipeline
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Eyestem to Start Human Trials for its Pioneering Dry AMD Treatment
Home
home_banner
Eyestem to Start Human Trials for its Pioneering Dry AMD Treatment
Post Author:
eyetem@admin
Post navigation
Previous Post
Eyestem files for IND approval for its product to treat Geographic Atrophy, the largest cause of incurable blindness in the world for people over 50